Here’s a quick glimpse of highlights from the June 2025 issue of The American Journal of Gastroenterology:
Browsing: Clinical Updates
At the 2025 National Lipid Association conference, a compelling shift emerged: GLP-1 receptor agonists like semaglutide (Ozempic) may protect the…
Colorectal cancer (CRC) remains the second leading cause of cancer death in the U.S.—even as incidence and mortality have declined.…
For patients with IBD, monitoring the disease often means enduring repeat colonoscopies—uncomfortable, invasive, and time-consuming. But Pfizer is helping change…
What if a workout routine could rival traditional cancer treatments? At the ASCO Annual Meeting, a groundbreaking trial revealed that…
In a landmark update, the NCCN has added two noninvasive tests—ColoSense and Shield—to its official colorectal cancer screening guidelines. ✅…
A rising tide of evidence suggests that complementary and mind-body therapies may be quietly transforming how we treat gastrointestinal (GI)…
Guardant Health just unveiled nearly a dozen new capabilities for its Guardant360® Liquid blood test—turning a routine draw into a…
Screening for colorectal cancer just got radically easier. New Day Diagnostics has launched ColoHealth™, a first-of-its-kind blood test available direct-to-consumer—no…
At DDW 2025, researchers unveiled a blood-based risk score that can predict the onset of Crohn’s disease (CD) up to…